Knight Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Knight Therapeutics has a total shareholder equity of CA$746.9M and total debt of CA$61.9M, which brings its debt-to-equity ratio to 8.3%. Its total assets and total liabilities are CA$945.5M and CA$198.6M respectively. Knight Therapeutics's EBIT is CA$6.4M making its interest coverage ratio -73.2. It has cash and short-term investments of CA$169.9M.
Key information
8.3%
Debt to equity ratio
CA$61.87m
Debt
Interest coverage ratio | -73.2x |
Cash | CA$169.87m |
Equity | CA$746.87m |
Total liabilities | CA$198.62m |
Total assets | CA$945.49m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: KHTR.F's short term assets (CA$365.1M) exceed its short term liabilities (CA$114.0M).
Long Term Liabilities: KHTR.F's short term assets (CA$365.1M) exceed its long term liabilities (CA$84.6M).
Debt to Equity History and Analysis
Debt Level: KHTR.F has more cash than its total debt.
Reducing Debt: KHTR.F's debt to equity ratio has increased from 0% to 8.3% over the past 5 years.
Debt Coverage: KHTR.F's debt is well covered by operating cash flow (58.1%).
Interest Coverage: KHTR.F earns more interest than it pays, so coverage of interest payments is not a concern.